Safety, Pharmacodynamics, and Pharmacokinetics of Orally Administered BLD-2660 in Subjects With IPF

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
A Phase 2a, Double-Blind, Placebo-Controlled Study to Evaluate Pharmacodynamics, Pharmacokinetics, and Safety of BLD-2660 Administered Orally in Subjects with Idiopathic Pulmonary Fibrosis
Epistemonikos ID: 1adf38bf08c5dba5f006ae31f59a2dcba55d8abb
First added on: May 07, 2024